TYRA (STOCKS)
Tyra Biosciences, Inc. Common Stock
$25.100000
-0.200000 (-0.79%)
Prev close: $25.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Todd J. Harris
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,495.44M
- Employees
- 60
- P/E (TTM)
- -10.46
- P/B (TTM)
- 4.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.69 | $-0.66 | -0.0274 | -4.14% |
|
Mar 2026 (Q1)
|
$-0.64 | $-0.60 | -0.0356 | -5.89% |
|
Dec 2025 (Q4)
|
$-0.57 | $-0.54 | -0.0313 | -5.81% |
|
Sep 2025 (Q3)
|
$-0.50 | $-0.51 | +0.0075 | +1.48% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $11.90M |
| Operating Expenses | $160.46M |
| Research and Development | $126.32M |
| Other Operating Expenses | $34.14M |
| Operating Income/Loss | -$160.46M |
| Income/Loss From Continuing Operations After Tax | -$148.57M |
| Income/Loss From Continuing Operations Before Tax | -$148.57M |
| Net Income/Loss | -$148.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$148.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$148.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.39 |
| Diluted Earnings Per Share | -$2.39 |
| Basic Average Shares | 187,486,329 |
| Diluted Average Shares | 123,629,445 |
| Assets | $383.36M |
| Current Assets | $366.97M |
| Noncurrent Assets | $16.40M |
| Fixed Assets | $1.17M |
| Other Non-current Assets | $15.22M |
| Liabilities | $29.70M |
| Current Liabilities | $24.62M |
| Accounts Payable | $2.33M |
| Other Current Liabilities | $22.29M |
| Noncurrent Liabilities | $5.08M |
| Equity | $353.66M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $353.66M |
| Liabilities And Equity | $383.36M |
| Net Cash Flow From Operating Activities | -$109.65M |
| Net Cash Flow From Operating Activities, Continuing | -$109.65M |
| Net Cash Flow From Investing Activities | -$82.82M |
| Net Cash Flow From Investing Activities, Continuing | -$82.82M |
| Net Cash Flow From Financing Activities | $167.82M |
| Net Cash Flow From Financing Activities, Continuing | $167.82M |
| Net Cash Flow | -$24.66M |
| Net Cash Flow, Continuing | -$24.66M |
| Comprehensive Income/Loss | -$149.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$149.58M |
| Other Comprehensive Income/Loss | -$149.58M |